Physiology · Blood, Immunity & Hemostasis
Blood is a specialized connective tissue composed of cellular elements suspended in plasma, performing critical roles in transportation, immunity, and hemostasis. It constitutes approximately 7-8% of total body weight, with plasma making up about 55% of its volume and formed elements—erythrocytes, leukocytes, and platelets—comprising the remainder. The unique composition of blood enables it to maintain homeostasis by delivering oxygen and nutrients, removing waste products, and defending against pathogens.
This topic explores the multifaceted functions of blood, focusing on its role in immune defense and hemostasis. Understanding the interplay between plasma proteins, cellular components, and regulatory mechanisms is essential for grasping how blood sustains life and responds to physiological and pathological challenges.
Plasma is the straw-colored liquid component of blood, consisting of 90% water and 10% solutes, including proteins, electrolytes, nutrients, gases, and waste products. The major plasma proteins—albumin, globulins, and fibrinogen—play pivotal roles in maintaining oncotic pressure, transporting substances, and facilitating coagulation. Albumin, synthesized by the liver, is the most abundant protein and is critical for regulating fluid distribution between the intravascular and interstitial spaces.
Erythrocytes, or red blood cells, are biconcave discs devoid of nuclei, optimized for oxygen transport via hemoglobin. Leukocytes, or white blood cells, are key players in immune defense and are categorized into granulocytes (neutrophils, eosinophils, basophils) and agranulocytes (lymphocytes, monocytes). Platelets, derived from megakaryocytes, are anucleate cell fragments essential for hemostasis, forming the primary plug during vascular injury and facilitating clot formation.
Blood immunity is mediated by leukocytes and plasma proteins, operating through innate and adaptive pathways. Innate immunity provides immediate, non-specific defense via neutrophils, monocytes, and the complement system, which opsonizes pathogens and induces inflammation. Adaptive immunity, driven by lymphocytes, offers antigen-specific responses: B cells produce antibodies for humoral immunity, while T cells orchestrate cell-mediated immunity, targeting infected or malignant cells.
Hemostasis is a tightly regulated process that prevents excessive blood loss following vascular injury, involving vascular spasm, platelet plug formation, and coagulation. Primary hemostasis begins with platelet adhesion to exposed collagen via von Willebrand factor, followed by platelet activation and aggregation. Secondary hemostasis, or coagulation, involves a cascade of enzymatic reactions culminating in the conversion of fibrinogen to fibrin, stabilizing the platelet plug. The coagulation cascade is divided into intrinsic and extrinsic pathways, converging at the common pathway with the activation of factor X.
Blood function is regulated by feedback mechanisms to maintain balance between procoagulant and anticoagulant factors. Anticoagulants such as antithrombin, protein C, and protein S inhibit excessive clotting, while fibrinolysis, mediated by plasmin, degrades clots to restore vascular patency. Disorders of blood function include anemia (reduced oxygen-carrying capacity), leukemias (malignant proliferation of leukocytes), and coagulopathies such as hemophilia (deficiency in clotting factors) or thrombophilia (hypercoagulable states).
Blood is a dynamic fluid composed of plasma and formed elements, each contributing to its roles in transportation, immunity, and hemostasis. Plasma proteins maintain oncotic pressure and facilitate coagulation, while erythrocytes, leukocytes, and platelets perform specialized functions in oxygen delivery, immune defense, and clot formation. Understanding the interplay between these components is essential for comprehending blood physiology.
Disruptions in hemostasis can lead to life-threatening conditions such as hemorrhage or thrombosis. Hemophilia, characterized by deficiencies in clotting factors VIII or IX, results in prolonged bleeding, while thrombophilia predisposes individuals to excessive clot formation, increasing the risk of deep vein thrombosis or pulmonary embolism. Therapeutic interventions, such as anticoagulants (e.g., warfarin, heparin) or antiplatelet agents (e.g., aspirin), are used to modulate these pathways in clinical practice.
Blood immunity is critical for defending against infections and malignancies. Immunodeficiencies, whether congenital (e.g., severe combined immunodeficiency) or acquired (e.g., HIV/AIDS), impair the body's ability to mount effective immune responses. Conversely, autoimmune disorders, such as systemic lupus erythematosus, result from dysregulated immune activity targeting self-antigens. Understanding these mechanisms informs the development of vaccines, immunotherapies, and immunosuppressive treatments.